Frank Runge

Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders

Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction

Range of Neurological Signs in Cynomolgus Monkeys After Intrathecal Bolus Administration of Antisense Oligonucleotides

A Decade in the MIST: Learnings from Investigations of Drug Metabolites in Drug Development under the “Metabolites in Safety Testing” Regulatory Guidance